246 related articles for article (PubMed ID: 8415897)
1. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I
Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
[TBL] [Abstract][Full Text] [Related]
2. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
5. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
6. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O
Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
[TBL] [Abstract][Full Text] [Related]
7. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn CK; Shrivastava R; Mendels J; Cohn JB; Fabre LF; Claghorn JL; Dessain EC; Itil TM; Lautin A
J Clin Psychiatry; 1990 Dec; 51 Suppl B():28-33. PubMed ID: 2258379
[TBL] [Abstract][Full Text] [Related]
9. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
[TBL] [Abstract][Full Text] [Related]
10. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
[TBL] [Abstract][Full Text] [Related]
11. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
12. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
[TBL] [Abstract][Full Text] [Related]
14. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
15. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
Kiev A
J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
[TBL] [Abstract][Full Text] [Related]
17. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
Fabre LF
J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
Reimherr FW; Chouinard G; Cohn CK; Cole JO; Itil TM; LaPierre YD; Masco HL; Mendels J
J Clin Psychiatry; 1990 Dec; 51 Suppl B():18-27. PubMed ID: 2258378
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
Bird H; Broggini M
J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
Claghorn JL
J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
